por
Gus Iversen, Editor in Chief | June 16, 2026
Boston Scientific plans to build a new medical device distribution facility in Plainfield, Indiana, a project expected to create up to 300 jobs and expand the company’s logistics capacity for global product shipments.
The Marlborough, Massachusetts-based medical device manufacturer said it expects to invest about $138 million in the project, which will include construction and equipment for a 500,000-square-foot facility at Plainfield Innovation Park. The company expects to begin construction later this year.
According to Indiana officials, the site will support Boston Scientific’s U.S.-based distribution and logistics operations and serve as a hub for the global distribution of medical devices. The facility is also expected to include light manufacturing functions and technology systems needed to support regulatory compliance.
Ad Statistics
Times Displayed: 7619
Times Visited: 17 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money.
Indiana Governor Mike Braun announced the project June 16, describing it as part of the state’s broader effort to expand its life sciences industry.
“Indiana’s commitment to further advancing our already robust life sciences sector continues to pay dividends as we welcome Boston Scientific to Plainfield,” Braun said in a statement.
The announcement comes several months after Braun unveiled a 10-year, $1 billion initiative aimed at growing Indiana’s agriculture and life sciences sectors. State leaders have said the program is intended to support research and development, commercialization, manufacturing, and logistics activities while helping create 100,000 high-wage jobs over the next decade.
Boston Scientific develops and manufactures medical technologies used in a range of specialties, including cardiovascular care, electrophysiology, endoscopy, urology and neuromodulation. The company said its products are used to treat more than 48 million patients annually worldwide.
Local officials said the project aligns with ongoing development plans in Plainfield, including efforts to attract life sciences, advanced manufacturing and logistics investments to areas south of Interstate 70.
